Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D) Rigid Gas Permeable Contact Lenses for Corneal Refractive Therapy for Temporary Myopic Refractive Power Reduction

NCT04187599 is registered in ClinicalTrials.gov with CooperVision International Limited (CVIL) as lead sponsor.

NCT NCT04187599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04187599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D) Rigid Gas Permeable Contact Lenses for Corneal Refractive Therapy for Temporary Myopic Refractive Power Reduction
Lead sponsor
CooperVision International Limited (CVIL)
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2019
Completion date
December 31, 2020
Enrollment
250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

myopia